AIM ImmunoTech Videos

AIM ImmunoTech News

AIM ImmunoTech Announces Further Efforts to Establish Clinical Trials Assessing Ampligen...

OCALA, FL / ACCESSWIRE / March 26, 2020 / AIM ImmunoTech (NYSE American:AIM) today announced that it is actively seeking investigators and sites for...

AIM ImmunoTech Provides Comprehensive Clinical Trials Update With Major Inflection Points...

Well Capitalized to Complete Current Ampligen Clinical Trials Following $10M in Capital Raises Plus $15M Recently Awarded by DOD to Roswell Park and Moffitt...

AIM ImmunoTech Articles

Hemispherx Bio up 22% on Ampligen + Keytruda studies: SeekingAlpha

Thinly traded nano cap Hemispherx Biopharma (HEB +22.1%) is up on a 7x surge in volume in reaction to its announcement of two clinical...
381cf01438895cab0b3756fba2d0131142708ac5e7aa3f1832